0.64CNY
174.11 MCNY
1.22 BCNY
187.67 M
About PULIKE BIOLOGICAL ENGINEERING，INC.
Sector
CEO
Fei Hu
Headquarters
Luoyang
Website
Employees (FY)
1.72 K
Founded
1995
ISIN
CNE1000025N0
FIGI
BBG002WTM467
Pulike Biological Engineering, Inc. engages in the research, development, manufacturing and sale of biological products for animals, chemical drugs and Chinese veterinary drugs. Its products include genetic engineering vaccines and multivalent vaccines. The company also provides technical services. Pulike Biological Engineering was founded in 1995 and is headquartered in Luoyang, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 603566 is 17.57 CNY — it has increased by 2.75% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange PULIKE BIOLOGICAL ENGINEERING，INC. stocks are traded under the ticker 603566.
PULIKE BIOLOGICAL ENGINEERING，INC. is going to release the next earnings report on Apr 26, 2024. Keep track of upcoming events with our Earnings Calendar.
603566 stock is 4.55% volatile and has beta coefficient of 1.30. Check out the list of the most volatile stocks — is PULIKE BIOLOGICAL ENGINEERING，INC. there?
One year price forecast for PULIKE BIOLOGICAL ENGINEERING，INC. has a max estimate of 28.00 CNY and a min estimate of 17.20 CNY.
PULIKE BIOLOGICAL ENGINEERING，INC. revenue for the last quarter amounts to 226.00 M CNY despite the estimated figure of 226.00 M CNY. In the next quarter revenue is expected to reach 267.00 M CNY.
Yes, you can track PULIKE BIOLOGICAL ENGINEERING，INC. financials in yearly and quarterly reports right on TradingView.
603566 stock has risen by 0.92% compared to the previous week, the month change is a 3.35% rise, over the last year PULIKE BIOLOGICAL ENGINEERING，INC. has showed a 34.34% decrease.
603566 net income for the last quarter is 61.61 M CNY, while the quarter before that showed 52.04 M CNY of net income which accounts for 18.40% change. Track more PULIKE BIOLOGICAL ENGINEERING，INC. financial stats to get the full picture.
Today PULIKE BIOLOGICAL ENGINEERING，INC. has the market capitalization of 5.80 B, it has increased by 0.11% over the last week.
PULIKE BIOLOGICAL ENGINEERING，INC. dividend yield was 1.28% in 2022, and payout ratio reached 64.81%. The year before the numbers were 0.90% and 25.78% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 603566 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PULIKE BIOLOGICAL ENGINEERING，INC. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 1.72 K employees. See our rating of the largest employees — is PULIKE BIOLOGICAL ENGINEERING，INC. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PULIKE BIOLOGICAL ENGINEERING，INC. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PULIKE BIOLOGICAL ENGINEERING，INC. stock shows the sell signal. See more of PULIKE BIOLOGICAL ENGINEERING，INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on PULIKE BIOLOGICAL ENGINEERING，INC. future price: according to them, 603566 price has a max estimate of 28.00 CNY and a min estimate of 17.20 CNY. Read a more detailed PULIKE BIOLOGICAL ENGINEERING，INC. forecast: see what analysts think of PULIKE BIOLOGICAL ENGINEERING，INC. and suggest that you do with its stocks.